Demand for accurate and fast testing methods in the fields of clinical diagnostics, food safety, and pharmaceutical production is a key factor driving the rapid microbiology testing market growth. Traditional testing techniques are labor-intensive and slows down the supply chain.
Sterile testing turnaround times have been considerably lowered from weeks to just 5-7 days thanks to advanced RMM devices including the BacT/ALERT Microbial Detection System, BACTEC System, and Milliflex Rapid System.
The 600 million cases of foodborne diseases every year signifies the need for rapid microbiological analysis in food safety. Technological developments in biosensors, spectrum imaging, and spectroscopic methods (such as MALDI MS) have greatly improved the precision and efficiency of microbial contamination detection in food products.
The rapid microbiology testing market is propelled by surge in healthcare expenditure in developed regions, improved healthcare infrastructure, and rise in global burden of infectious diseases. DNA-based identification technologies are quick in identifying diseases; they supplement traditional techniques rather than completely replacing them.
New technologies have the potential to diagnose sepsis quickly by combining phenotypic antibiogram capabilities, such as MIC values, with rapid pathogen identification.
The sensitivity, accuracy, and repeatability of the new techniques, such as PCR, ELISA, MALDI MS, and ATP bioluminescence, have reduced the waiting time for reports. These developments have improved antimicrobial stewardship and allowed for quicker decision-making.
North America and Europe have well-developed healthcare systems with significant investments in research and development. Asia Pacific is seeing rapid market progress due to increase in understanding of early detection and health facility improvement.
The need for speedy and effective microbiological testing to meet the requirement for precise as well as timely microbial diagnostics is expected to bolster the rapid microbiology testing industry in the short term.
| Attribute | Detail |
|---|---|
| Drivers |
|
The time needed for pathogen detection and identification has been greatly reduced due to automation and downsizing of microbiological assays. This is the result of recent technological developments.
Microbial diagnostics can be done more quickly and effectively because of the integration of several laboratory procedures into a single device made possible by miniaturized systems, such as lab-on-a-chip technology.
Microbial screenings have become highly reliable and consistent since it has been automated, leading to reduction in human error and optimizing throughput.
These technological advancements have a significant impact on clinical research and diagnosis where early diagnosis might benefit patient health outcomes, particularly in sepsis and bloodstream infection, which require immediate response.
Reduced test times, enhanced laboratory efficiency, and lower operational costs while simultaneously speeding up patient treatment are augmenting the rapid microbiology testing market value.
The rapid microbiological testing technique has significant impacted medical diagnostics, allowing for the quick detection of causal organisms and also its resistances toward drugs. This step is critical for treatment of serious infections such as pneumonia and sepsis.
Early and correct diagnosis reduces the likelihood of mortality and sequelae in patients. Multiplex PCR and MALDI-TOF MS techniques give quicker results than conventional processes, allowing doctors and physicians to make more informed judgments.
The combination of these diagnostic techniques with antimicrobial stewardship programs (ASPs) improves patient health outcomes by ensuring antibiotics are used appropriately and preventing microbial resistance. This integrated strategy improves healthcare quality by supporting proper antibiotic usage and successful infectious disease treatment.
The rapid microbiology testing market segmentation based on product includes instruments, kits and reagents, and software and services. The kits and reagents segment dominates the industry as they are consumable and required frequently for the assays.
The chemicals and reagents are essential for conducting testing protocols because they include the chemicals and compounds needed to perform pathogen identification assays.
Reagents and kits demand a lesser initial investment than acquiring new instruments, making them more financially accessible for smaller labs or those with limited funds.
Rapid turnover and reagent consumption offer producers with a stable income stream, assuring consistent market demand and assisting in the sustainability of corporate operations.
These factors combine to increase the significance of kits and reagents in the rapid microbiological testing market, making them the dominating category when compared to instruments, services, and software.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the rapid microbiology testing market analysis, North America dominates the landscape. Strict regulatory requirements are driving market dynamics in North America, specifically in the United States.
Strong healthcare infrastructure and considerable expenditure in research & development activities also offers lucrative rapid microbiology testing industry opportunities in the region.
The Clinical and Laboratory Standards Institute (CLSI) establishes stringent standards that results in the use of modern testing procedures, which leads to high accuracy and dependability in diagnostic outcomes.
As per the microbiological testing industry report, the region's healthcare infrastructure works in collaboration with universities and industries, constantly creating new rapid screening techniques, such as the Accelerated Diagnostics' Accelerate Pheno system.
The surge in prevalence of infectious illnesses, as well as the need for efficient antimicrobial stewardship programs, are driving demand for rapid microbiology tests, which enables faster diagnosis and treatment while lowering antibiotic resistance. These factors strengthen North America's position in the market.
The market is highly competitive and has a strong presence of key players. The rapid microbiology testing market report highlights that leading players are adopting strategies such as acquisition and launching of new products.
Biomerieux SA, Becton, Dickinson and Company, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Merck KGAA Bruker, Quidelortho Corporation, Sartorius AG, Charles River Laboratories, Neogen Corporation, Bio-Rad, Creative Diagnostics, Hi-Media, Merlin, Zhuhai DL Biotech, and Rapid Micro Biosystems are the prominent rapid microbiology testing market manufacturers.
Key players have been profiled in the rapid microbiology testing market research report, based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Market Value in 2023 | US$ 4.1 Bn |
| Forecast (Value) in 2034 | US$ 7.6 Bn |
| Growth Rate (CAGR) | 5.7% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It provides segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 4.1 Bn in 2023
It is projected to reach more than US$ 7.6 Bn by the end of 2034
The CAGR is anticipated to be 5.7% from 2024 to 2034
Advances in miniaturization and automation significantly cuts assay time, resulting in high demand
In terms of product, the kits and reagents segment accounted for major share in 2023
North America is expected to account for major share during the forecast period
Biomerieux SA, Becton, Dickinson and Company, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Merck KGAA Bruker, Quidelortho Corporation, Sartorius AG, Charles River Laboratories, Neogen Corporation, Bio-Rad, Creative Diagnostics, Hi-Media, Merlin, Zhuhai DL Biotech, and Rapid Micro Biosystems
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Rapid Microbiology Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Rapid Microbiology Testing Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Value Chain Analysis
5.2. Regulatory Scenario by Countries
5.3. Key Product/ Brand Analysis
5.4. Government Initiatives
5.5. Technological Advancements
5.6. Key Industry Events
5.7. PESTEL Analysis
5.8. KOL’s Opinion
5.9. Unmet Needs
6. Global Rapid Microbiology Testing Market Analysis and Forecasts, By Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product, 2020-2034
6.3.1. Instruments
6.3.1.1. Automated Microbial Identification System
6.3.1.2. PCR
6.3.1.3. Mass Spectrometer
6.3.1.4. Others
6.3.2. Kits and Reagents
6.3.3. Software and Services
6.4. Market Attractiveness By Product
7. Global Rapid Microbiology Testing Market Analysis and Forecasts, By End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By End-user, 2020-2034
7.3.1. Clinical diagnosis
7.3.1.1. Hospitals & Clinics
7.3.1.2. Diagnostic Laboratories
7.3.2. Industrial Research
7.3.2.1. Pharma & Biotech Companies
7.3.2.2. Food & Beverages
7.3.2.3. Cosmetic
7.3.2.4. Environmental Research
7.3.2.5. Others
7.3.3. Research Application
7.3.3.1. CRO & CMO
7.3.3.2. Academic & Research Institutes
7.4. Market Attractiveness By End-user
8. Global Rapid Microbiology Testing Market Analysis and Forecasts, By Region
8.1. Key Findings
8.2. Market Value Forecast By Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness By Country/Region
9. North America Rapid Microbiology Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast By Product, 2020-2034
9.2.1. Instruments
9.2.1.1. Automated Microbial Identification System
9.2.1.2. PCR
9.2.1.3. Mass Spectrometer
9.2.1.4. Others
9.2.2. Kits and Reagents
9.2.3. Software and Services
9.3. Market Value Forecast By End-user, 2020-2034
9.3.1. Clinical diagnosis
9.3.1.1. Hospitals & Clinics
9.3.1.2. Diagnostic Laboratories
9.3.2. Industrial Research
9.3.2.1. Pharma & Biotech Companies
9.3.2.2. Food & Beverages
9.3.2.3. Cosmetic
9.3.2.4. Environmental Research
9.3.2.5. Others
9.3.3. Research Application
9.3.3.1. CRO & CMO
9.3.3.2. Academic & Research Institutes
9.4. Market Value Forecast By Country, 2020-2034
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Rapid Microbiology Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Product, 2020-2034
10.2.1. Instruments
10.2.1.1. Automated Microbial Identification System
10.2.1.2. PCR
10.2.1.3. Mass Spectrometer
10.2.1.4. Others
10.2.2. Kits and Reagents
10.2.3. Software and Services
10.3. Market Value Forecast By End-user, 2020-2034
10.3.1. Clinical diagnosis
10.3.1.1. Hospitals & Clinics
10.3.1.2. Diagnostic Laboratories
10.3.2. Industrial Research
10.3.2.1. Pharma & Biotech Companies
10.3.2.2. Food & Beverages
10.3.2.3. Cosmetic
10.3.2.4. Environmental Research
10.3.2.5. Others
10.3.3. Research Application
10.3.3.1. CRO & CMO
10.3.3.2. Academic & Research Institutes
10.4. Market Value Forecast By Country/Sub-region, 2020-2034
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Rapid Microbiology Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product, 2020-2034
11.2.1. Instruments
11.2.1.1. Automated Microbial Identification System
11.2.1.2. PCR
11.2.1.3. Mass Spectrometer
11.2.1.4. Others
11.2.2. Kits and Reagents
11.2.3. Software and Services
11.3. Market Value Forecast By End-user, 2020-2034
11.3.1. Clinical diagnosis
11.3.1.1. Hospitals & Clinics
11.3.1.2. Diagnostic Laboratories
11.3.2. Industrial Research
11.3.2.1. Pharma & Biotech Companies
11.3.2.2. Food & Beverages
11.3.2.3. Cosmetic
11.3.2.4. Environmental Research
11.3.2.5. Others
11.3.3. Research Application
11.3.3.1. CRO & CMO
11.3.3.2. Academic & Research Institutes
11.4. Market Value Forecast By Country/Sub-region, 2020-2034
11.4.1. China
11.4.2. India
11.4.3. Japan
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Rapid Microbiology Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product, 2020-2034
12.2.1. Instruments
12.2.1.1. Automated Microbial Identification System
12.2.1.2. PCR
12.2.1.3. Mass Spectrometer
12.2.1.4. Others
12.2.2. Kits and Reagents
12.2.3. Software and Services
12.3. Market Value Forecast By End-user, 2020-2034
12.3.1. Clinical diagnosis
12.3.1.1. Hospitals & Clinics
12.3.1.2. Diagnostic Laboratories
12.3.2. Industrial Research
12.3.2.1. Pharma & Biotech Companies
12.3.2.2. Food & Beverages
12.3.2.3. Cosmetic
12.3.2.4. Environmental Research
12.3.2.5. Others
12.3.3. Research Application
12.3.3.1. CRO & CMO
12.3.3.2. Academic & Research Institutes
12.4. Market Value Forecast By Country/Sub-region, 2020-2034
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Rapid Microbiology Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product, 2020-2034
13.2.1. Instruments
13.2.1.1. Automated Microbial Identification System
13.2.1.2. PCR
13.2.1.3. Mass Spectrometer
13.2.1.4. Others
13.2.2. Kits and Reagents
13.2.3. Software and Services
13.3. Market Value Forecast By End-user, 2020-2034
13.3.1. Clinical diagnosis
13.3.1.1. Hospitals & Clinics
13.3.1.2. Diagnostic Laboratories
13.3.2. Industrial Research
13.3.2.1. Pharma & Biotech Companies
13.3.2.2. Food & Beverages
13.3.2.3. Cosmetic
13.3.2.4. Environmental Research
13.3.2.5. Others
13.3.3. Research Application
13.3.3.1. CRO & CMO
13.3.3.2. Academic & Research Institutes
13.4. Market Value Forecast By Country/Sub-region, 2020-2034
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis By Company (2022)
14.3. Company Profiles
14.3.1. Biomerieux SA
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Becton, Dickinson and Company
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Danaher Corporation
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Abbott Laboratories
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Thermo Fisher Scientific
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Merck KGAA
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Bruker
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Quidelortho Corporation
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Sartorius AG
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Charles River Laboratories
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. Neogen Corporation
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Portfolio
14.3.11.3. Financial Overview
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview
14.3.12. Bio-Rad
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Product Portfolio
14.3.12.3. Financial Overview
14.3.12.4. SWOT Analysis
14.3.12.5. Strategic Overview
14.3.13. Creative Diagnostics
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Product Portfolio
14.3.13.3. Financial Overview
14.3.13.4. SWOT Analysis
14.3.13.5. Strategic Overview
14.3.14. Hi-Media
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Product Portfolio
14.3.14.3. Financial Overview
14.3.14.4. SWOT Analysis
14.3.14.5. Strategic Overview
14.3.15. Merlin
14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.15.2. Product Portfolio
14.3.15.3. Financial Overview
14.3.15.4. SWOT Analysis
14.3.15.5. Strategic Overview
14.3.16. Zhuhai DL Biotech
14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.16.2. Product Portfolio
14.3.16.3. Financial Overview
14.3.16.4. SWOT Analysis
14.3.16.5. Strategic Overview
14.3.17. Rapid Micro Biosystems
14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.17.2. Product Portfolio
14.3.17.3. Financial Overview
14.3.17.4. SWOT Analysis
14.3.17.5. Strategic Overview
14.3.18. Other Prominent Players
14.3.18.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.18.2. Product Portfolio
14.3.18.3. Financial Overview
14.3.18.4. SWOT Analysis
14.3.18.5. Strategic Overview
List of Tables
Table 01: Global Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Product, 2020-2034
Table 02: Global Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Product, 2020-2034
Table 03: Global Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 04: Global Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Clinical diagnosis, 2020-2034
Table 05: Global Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Industrial Research, 2020-2034
Table 06: Global Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Reseach Application, 2020-2034
Table 07: Global Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Region, 2020-2034
Table 08: North America Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Country, 2020-2034
Table 09: North America Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Product, 2020-2034
Table 10: North America Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Product, 2020-2034
Table 11: North America Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 12: North America Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Clinical diagnosis, 2020-2034
Table 13: North America Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Industrial Research, 2020-2034
Table 14: North America Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Reseach Application, 2020-2034
Table 15: Europe Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 16: Europe Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Product, 2020-2034
Table 17: Europe Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Product, 2020-2034
Table 18: Europe Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 19: Europe Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Clinical diagnosis, 2020-2034
Table 20: Europe Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Industrial Research, 2020-2034
Table 21: Europe Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Reseach Application, 2020-2034
Table 22: Asia Pacific Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 23: Asia Pacific Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Product, 2020-2034
Table 24: Asia Pacific Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Product, 2020-2034
Table 25: Asia Pacific Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 26: Asia Pacific Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Clinical diagnosis, 2020-2034
Table 27: Asia Pacific Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Industrial Research, 2020-2034
Table 28: Asia Pacific Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Reseach Application, 2020-2034
Table 29: Latin America Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 30: Latin America Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Product, 2020-2034
Table 31: Latin America Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Product, 2020-2034
Table 32: Latin America Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 33: Latin America Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Clinical diagnosis, 2020-2034
Table 34: Latin America Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Industrial Research, 2020-2034
Table 35: Latin America Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Reseach Application, 2020-2034
Table 36: Middle East & Africa Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 37: Middle East & Africa Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Product, 2020-2034
Table 38: Middle East & Africa Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Product, 2020-2034
Table 39: Middle East & Africa Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 40: Middle East & Africa Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Clinical diagnosis, 2020-2034
Table 41: Middle East & Africa Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Industrial Research, 2020-2034
Table 42: Middle East & Africa Rapid Microbiology Testing Market Value (US$ Mn) Forecast, by Reseach Application, 2020-2034
List of Figures
Figure 01: Rapid Microbiology Testing Market Size, by Product, 2023
Figure 02: Rapid Microbiology Testing Market share (%), by Product, 2023
Figure 03: Rapid Microbiology Testing Market Size, by End-user, 2023
Figure 04: Rapid Microbiology Testing Market share (%), by End-user, 2023
Figure 05: Global Rapid Microbiology Testing Market, By Region (2023 and 2034)
Figure 06: Global Rapid Microbiology Testing Market Value (US$ Mn) Forecast, 2020-2034
Figure 07: Global Rapid Microbiology Testing Market Value Share Analysis, by Product, 2023 and 2034
Figure 08: Global Rapid Microbiology Testing Market Value Share Analysis, by Product, 2023
Figure 09: Global Rapid Microbiology Testing Market Value Share Analysis, by Product, 2034
Figure 10: Global Rapid Microbiology Testing Market Attractiveness Analysis, by Product, 2023-2034
Figure 11: Global Rapid Microbiology Testing Market Value (US$ Mn), by Instruments, 2020‒2034
Figure 12: Global Rapid Microbiology Testing Market Value Share Analysis, by Instruments, 2023 and 2034
Figure 13: Global Rapid Microbiology Testing Market Value (US$ Mn), by Kits and Reagents, 2020‒2034
Figure 14: Global Rapid Microbiology Testing Market Value Share Analysis, Kits and Reagents, 2023 and 2034
Figure 15: Global Rapid Microbiology Testing Market Value (US$ Mn), by Software and Services, 2020‒2034
Figure 16: Global Rapid Microbiology Testing Market Value Share Analysis, by Software and Services, 2023 and 2034
Figure 17: Global Rapid Microbiology Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 18: Global Rapid Microbiology Testing Market Value Share Analysis, by End-user, 2023
Figure 19: Global Rapid Microbiology Testing Market Value Share Analysis, by End-user, 2034
Figure 20: Global Rapid Microbiology Testing Market Attractiveness Analysis, by End-user, 2023-2034
Figure 21: Global Rapid Microbiology Testing Market Value (US$ Mn), by Clinical diagnosis, 2020‒2034
Figure 22: Global Rapid Microbiology Testing Market Value Share Analysis, by Clinical diagnosis, 2023 and 2034
Figure 23: Global Rapid Microbiology Testing Market Value (US$ Mn), by Industrial Research , 2020‒2034
Figure 24: Global Rapid Microbiology Testing Market Value Share Analysis, Industrial Research , 2023 and 2034
Figure 25: Global Rapid Microbiology Testing Market Value (US$ Mn), by Research Application , 2020‒2034
Figure 26: Global Rapid Microbiology Testing Market Value Share Analysis, by Research Application , 2023 and 2034
Figure 27: Global Rapid Microbiology Testing Market Value Share Analysis, by Region, 2023 and 2034
Figure 28: Global Rapid Microbiology Testing Market Attractiveness Analysis, by Region, 2023-2034
Figure 29: North America Rapid Microbiology Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 30: North America Rapid Microbiology Testing Market Value Share Analysis, by Country, 2023 and 2034
Figure 31: North America Rapid Microbiology Testing Market Attractiveness Analysis, by Country, 2023-2034
Figure 32: North America Rapid Microbiology Testing Market Value Share Analysis, by Product, 2023 and 2034
Figure 33: North America Rapid Microbiology Testing Market Attractiveness Analysis, by Product, 2023-2034
Figure 34: North America Rapid Microbiology Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 35: North America Rapid Microbiology Testing Market Attractiveness Analysis, by End-user, 2023-2034
Figure 36: Europe Rapid Microbiology Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 37: Europe Rapid Microbiology Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 38: Europe Rapid Microbiology Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
Figure 39: Europe Rapid Microbiology Testing Market Value Share Analysis, by Product, 2023 and 2034
Figure 40: Europe Rapid Microbiology Testing Market Attractiveness Analysis, by Product, 2023-2034
Figure 41: Europe Rapid Microbiology Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Europe Rapid Microbiology Testing Market Attractiveness Analysis, by End-user, 2023-2034
Figure 43: Asia Pacific Rapid Microbiology Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 44: Asia Pacific Rapid Microbiology Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 45: Asia Pacific Rapid Microbiology Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
Figure 46: Asia Pacific Rapid Microbiology Testing Market Value Share Analysis, by Product, 2023 and 2034
Figure 47: Asia Pacific Rapid Microbiology Testing Market Attractiveness Analysis, by Product, 2023-2034
Figure 48: Asia Pacific Rapid Microbiology Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 49: Asia Pacific Rapid Microbiology Testing Market Attractiveness Analysis, by End-user, 2023-2034
Figure 50: Latin America Rapid Microbiology Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 51: Latin America Rapid Microbiology Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 52: Latin America Rapid Microbiology Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
Figure 53: Latin America Rapid Microbiology Testing Market Value Share Analysis, by Product, 2023 and 2034
Figure 54: Latin America Rapid Microbiology Testing Market Attractiveness Analysis, by Product, 2023-2034
Figure 55: Latin America Rapid Microbiology Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 56: Latin America Rapid Microbiology Testing Market Attractiveness Analysis, by End-user, 2023-2034
Figure 57: Middle East & Africa Rapid Microbiology Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 58: Middle East & Africa Rapid Microbiology Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 59: Middle East & Africa Rapid Microbiology Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
Figure 60: Middle East & Africa Rapid Microbiology Testing Market Value Share Analysis, by Product, 2023 and 2034
Figure 61: Middle East & Africa Rapid Microbiology Testing Market Attractiveness Analysis, by Product, 2023-2034
Figure 62: Middle East & Africa Rapid Microbiology Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 63: Middle East & Africa Rapid Microbiology Testing Market Attractiveness Analysis, by End-user, 2023-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Rapid Microbiology Testing Market
